Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01883102 · ClinicalTrials.gov registry record · Phase 1
The Effect of Ablation of Epidermal Nerve Fibers Using Capsaicin Cream
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT01883102: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT01883102 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01883102, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is a study of epidermal (the outer most layer) nerve fibers (ENFs) in the skin of the body; counts of which are used to determine a disease of nerves called "small nerve fiber neuropathy." Capsaicin is approved by the Food and Drug Administration (FDA) for pain relief. Since 0.1% capsaicin is known to cause ablation (removal) of ENFs, this study will test whether such ablation results in relief of spontaneous pain, touch, or heat-pain.
Interventions
- DRUG Placebo
- DRUG Capsaicin 0.1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-06 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01883102
The ClinicalTrials.gov registry entry for NCT01883102 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01883102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01883102 about?
NCT01883102 is a clinical study titled "The Effect of Ablation of Epidermal Nerve Fibers Using Capsaicin Cream". This is a study of epidermal (the outer most layer) nerve fibers (ENFs) in the skin of the body; counts of which are used to determine a disease of nerves called "small nerve fiber neuropathy." Capsaicin is approved by the Food and Drug Administration (FDA) for pain relief. Since 0.1% capsaicin is ...
What is the current status of trial NCT01883102?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2013-06. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01883102?
The interventions under investigation include: Placebo (DRUG), Capsaicin 0.1% (DRUG).
Who is sponsoring clinical trial NCT01883102?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.